IMMUNIC, INC. — Director's Dealing 2016

May 26, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VITAL THERAPIES INC (VTL)
CIK: 0001280776
Period of Report: 2016-05-24

Reporting Person: SEARS LOWELL (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-24	Stock Option (right to buy)	$8.17	A	21599	Acquired	2026-05-23	Common Stock (21599.0)	Direct

Footnotes

F1: Subject to reporting person's continuing to be a Service Provider (as defined in the 2014 Equity Incentive Plan) through the vesting date, 100% of the shares subject to the option shall vest and become exercisable upon the earlier of the one (1) year anniversary from May 24, 2016 or the day prior to the Company's 2017 annual meeting of stockholders.